ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Long-acting Recombinant Human Erythropoietin Injections Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-21H15682
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Long acting Recombinant Human Erythropoietin Injections Market Research Report 2023
BUY CHAPTERS

Global Long-acting Recombinant Human Erythropoietin Injections Market Research Report 2025

Code: QYRE-Auto-21H15682
Report
May 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Johnson & Johnson
Kyowa Kirin

Long-acting Recombinant Human Erythropoietin Injections Market Size

The global market for Long-acting Recombinant Human Erythropoietin Injections was valued at US$ 921 million in the year 2024 and is projected to reach a revised size of US$ 1324 million by 2031, growing at a CAGR of 5.4% during the forecast period.

Long-acting Recombinant Human Erythropoietin Injections Market

Long-acting Recombinant Human Erythropoietin Injections Market

Long-acting erythropoietin (EPO) drugs are a type of medication used to stimulate the production of red blood cells in the body. These drugs are primarily prescribed for individuals with certain medical conditions, such as anemia associated with chronic kidney disease or cancer treatment.
The market for long-acting recombinant human erythropoietin injections is a vital biopharmaceutical product used primarily in the treatment of anemia, particularly associated with kidney disease and anemia resulting from chemotherapy in leukemia. The market is substantial and continues to grow, benefitting from the ongoing expansion of global healthcare systems and the persistent demand for anemia treatments. In the future, with the continued advancement of biotechnology and increasing therapeutic needs, long-acting recombinant human erythropoietin injections are poised for further development, potentially involving broader application areas and improved therapeutic solutions to offer more effective anemia management for patients.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Long-acting Recombinant Human Erythropoietin Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting Recombinant Human Erythropoietin Injections.
The Long-acting Recombinant Human Erythropoietin Injections market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-acting Recombinant Human Erythropoietin Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Long-acting Recombinant Human Erythropoietin Injections manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Long-acting Recombinant Human Erythropoietin Injections Market Report

Report Metric Details
Report Name Long-acting Recombinant Human Erythropoietin Injections Market
Accounted market size in year US$ 921 million
Forecasted market size in 2031 US$ 1324 million
CAGR 5.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Epoetin-alfa
  • Epoetin-beta
  • Darbepoetin-alfa
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen, Johnson & Johnson, Kyowa Kirin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Long-acting Recombinant Human Erythropoietin Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Long-acting Recombinant Human Erythropoietin Injections in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Long-acting Recombinant Human Erythropoietin Injections Market growing?

Ans: The Long-acting Recombinant Human Erythropoietin Injections Market witnessing a CAGR of 5.4% during the forecast period 2025-2031.

What is the Long-acting Recombinant Human Erythropoietin Injections Market size in 2031?

Ans: The Long-acting Recombinant Human Erythropoietin Injections Market size in 2031 will be US$ 1324 million.

Who are the main players in the Long-acting Recombinant Human Erythropoietin Injections Market report?

Ans: The main players in the Long-acting Recombinant Human Erythropoietin Injections Market are Amgen, Johnson & Johnson, Kyowa Kirin

What are the Application segmentation covered in the Long-acting Recombinant Human Erythropoietin Injections Market report?

Ans: The Applications covered in the Long-acting Recombinant Human Erythropoietin Injections Market report are Anemia, Kidney Disorders, Others

What are the Type segmentation covered in the Long-acting Recombinant Human Erythropoietin Injections Market report?

Ans: The Types covered in the Long-acting Recombinant Human Erythropoietin Injections Market report are Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others

Recommended Reports

Recombinant Pharmaceuticals

Hemoglobin & Anemia

Injectable Therapeutics

1 Long-acting Recombinant Human Erythropoietin Injections Market Overview
1.1 Product Definition
1.2 Long-acting Recombinant Human Erythropoietin Injections by Type
1.2.1 Global Long-acting Recombinant Human Erythropoietin Injections Market Value Comparison by Type (2024 VS 2031)
1.2.2 Epoetin-alfa
1.2.3 Epoetin-beta
1.2.4 Darbepoetin-alfa
1.2.5 Others
1.3 Long-acting Recombinant Human Erythropoietin Injections by Application
1.3.1 Global Long-acting Recombinant Human Erythropoietin Injections Market Value by Application (2024 VS 2031)
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Others
1.4 Global Long-acting Recombinant Human Erythropoietin Injections Market Size Estimates and Forecasts
1.4.1 Global Long-acting Recombinant Human Erythropoietin Injections Revenue 2020-2031
1.4.2 Global Long-acting Recombinant Human Erythropoietin Injections Sales 2020-2031
1.4.3 Global Long-acting Recombinant Human Erythropoietin Injections Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Long-acting Recombinant Human Erythropoietin Injections Market Competition by Manufacturers
2.1 Global Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Manufacturers (2020-2025)
2.2 Global Long-acting Recombinant Human Erythropoietin Injections Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Long-acting Recombinant Human Erythropoietin Injections Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Long-acting Recombinant Human Erythropoietin Injections, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Long-acting Recombinant Human Erythropoietin Injections, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Long-acting Recombinant Human Erythropoietin Injections, Product Type & Application
2.7 Global Key Manufacturers of Long-acting Recombinant Human Erythropoietin Injections, Date of Enter into This Industry
2.8 Global Long-acting Recombinant Human Erythropoietin Injections Market Competitive Situation and Trends
2.8.1 Global Long-acting Recombinant Human Erythropoietin Injections Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Long-acting Recombinant Human Erythropoietin Injections Players Market Share by Revenue
2.8.3 Global Long-acting Recombinant Human Erythropoietin Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-acting Recombinant Human Erythropoietin Injections Market Scenario by Region
3.1 Global Long-acting Recombinant Human Erythropoietin Injections Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Long-acting Recombinant Human Erythropoietin Injections Sales by Region: 2020-2031
3.2.1 Global Long-acting Recombinant Human Erythropoietin Injections Sales by Region: 2020-2025
3.2.2 Global Long-acting Recombinant Human Erythropoietin Injections Sales by Region: 2026-2031
3.3 Global Long-acting Recombinant Human Erythropoietin Injections Revenue by Region: 2020-2031
3.3.1 Global Long-acting Recombinant Human Erythropoietin Injections Revenue by Region: 2020-2025
3.3.2 Global Long-acting Recombinant Human Erythropoietin Injections Revenue by Region: 2026-2031
3.4 North America Long-acting Recombinant Human Erythropoietin Injections Market Facts & Figures by Country
3.4.1 North America Long-acting Recombinant Human Erythropoietin Injections Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Long-acting Recombinant Human Erythropoietin Injections Sales by Country (2020-2031)
3.4.3 North America Long-acting Recombinant Human Erythropoietin Injections Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-acting Recombinant Human Erythropoietin Injections Market Facts & Figures by Country
3.5.1 Europe Long-acting Recombinant Human Erythropoietin Injections Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Long-acting Recombinant Human Erythropoietin Injections Sales by Country (2020-2031)
3.5.3 Europe Long-acting Recombinant Human Erythropoietin Injections Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-acting Recombinant Human Erythropoietin Injections Market Facts & Figures by Region
3.6.1 Asia Pacific Long-acting Recombinant Human Erythropoietin Injections Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Long-acting Recombinant Human Erythropoietin Injections Sales by Region (2020-2031)
3.6.3 Asia Pacific Long-acting Recombinant Human Erythropoietin Injections Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-acting Recombinant Human Erythropoietin Injections Market Facts & Figures by Country
3.7.1 Latin America Long-acting Recombinant Human Erythropoietin Injections Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Long-acting Recombinant Human Erythropoietin Injections Sales by Country (2020-2031)
3.7.3 Latin America Long-acting Recombinant Human Erythropoietin Injections Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Long-acting Recombinant Human Erythropoietin Injections Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-acting Recombinant Human Erythropoietin Injections Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Long-acting Recombinant Human Erythropoietin Injections Sales by Country (2020-2031)
3.8.3 Middle East and Africa Long-acting Recombinant Human Erythropoietin Injections Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-acting Recombinant Human Erythropoietin Injections Sales by Type (2020-2031)
4.1.1 Global Long-acting Recombinant Human Erythropoietin Injections Sales by Type (2020-2025)
4.1.2 Global Long-acting Recombinant Human Erythropoietin Injections Sales by Type (2026-2031)
4.1.3 Global Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Type (2020-2031)
4.2 Global Long-acting Recombinant Human Erythropoietin Injections Revenue by Type (2020-2031)
4.2.1 Global Long-acting Recombinant Human Erythropoietin Injections Revenue by Type (2020-2025)
4.2.2 Global Long-acting Recombinant Human Erythropoietin Injections Revenue by Type (2026-2031)
4.2.3 Global Long-acting Recombinant Human Erythropoietin Injections Revenue Market Share by Type (2020-2031)
4.3 Global Long-acting Recombinant Human Erythropoietin Injections Price by Type (2020-2031)
5 Segment by Application
5.1 Global Long-acting Recombinant Human Erythropoietin Injections Sales by Application (2020-2031)
5.1.1 Global Long-acting Recombinant Human Erythropoietin Injections Sales by Application (2020-2025)
5.1.2 Global Long-acting Recombinant Human Erythropoietin Injections Sales by Application (2026-2031)
5.1.3 Global Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Application (2020-2031)
5.2 Global Long-acting Recombinant Human Erythropoietin Injections Revenue by Application (2020-2031)
5.2.1 Global Long-acting Recombinant Human Erythropoietin Injections Revenue by Application (2020-2025)
5.2.2 Global Long-acting Recombinant Human Erythropoietin Injections Revenue by Application (2026-2031)
5.2.3 Global Long-acting Recombinant Human Erythropoietin Injections Revenue Market Share by Application (2020-2031)
5.3 Global Long-acting Recombinant Human Erythropoietin Injections Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Company Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Long-acting Recombinant Human Erythropoietin Injections Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen Long-acting Recombinant Human Erythropoietin Injections Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Long-acting Recombinant Human Erythropoietin Injections Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Long-acting Recombinant Human Erythropoietin Injections Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Kyowa Kirin
6.3.1 Kyowa Kirin Company Information
6.3.2 Kyowa Kirin Description and Business Overview
6.3.3 Kyowa Kirin Long-acting Recombinant Human Erythropoietin Injections Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Kyowa Kirin Long-acting Recombinant Human Erythropoietin Injections Product Portfolio
6.3.5 Kyowa Kirin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-acting Recombinant Human Erythropoietin Injections Industry Chain Analysis
7.2 Long-acting Recombinant Human Erythropoietin Injections Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-acting Recombinant Human Erythropoietin Injections Production Mode & Process Analysis
7.4 Long-acting Recombinant Human Erythropoietin Injections Sales and Marketing
7.4.1 Long-acting Recombinant Human Erythropoietin Injections Sales Channels
7.4.2 Long-acting Recombinant Human Erythropoietin Injections Distributors
7.5 Long-acting Recombinant Human Erythropoietin Injections Customer Analysis
8 Long-acting Recombinant Human Erythropoietin Injections Market Dynamics
8.1 Long-acting Recombinant Human Erythropoietin Injections Industry Trends
8.2 Long-acting Recombinant Human Erythropoietin Injections Market Drivers
8.3 Long-acting Recombinant Human Erythropoietin Injections Market Challenges
8.4 Long-acting Recombinant Human Erythropoietin Injections Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Amgen Inc
Johnson & Johnson
Kyowa Kirin
List of Tables
 Table 1. Global Long-acting Recombinant Human Erythropoietin Injections Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Long-acting Recombinant Human Erythropoietin Injections Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Long-acting Recombinant Human Erythropoietin Injections Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Long-acting Recombinant Human Erythropoietin Injections Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Long-acting Recombinant Human Erythropoietin Injections Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Long-acting Recombinant Human Erythropoietin Injections Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Long-acting Recombinant Human Erythropoietin Injections Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Long-acting Recombinant Human Erythropoietin Injections, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Long-acting Recombinant Human Erythropoietin Injections, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Long-acting Recombinant Human Erythropoietin Injections, Product Type & Application
 Table 12. Global Key Manufacturers of Long-acting Recombinant Human Erythropoietin Injections, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Long-acting Recombinant Human Erythropoietin Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Recombinant Human Erythropoietin Injections as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Long-acting Recombinant Human Erythropoietin Injections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Long-acting Recombinant Human Erythropoietin Injections Sales by Region (2020-2025) & (K Units)
 Table 18. Global Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Region (2020-2025)
 Table 19. Global Long-acting Recombinant Human Erythropoietin Injections Sales by Region (2026-2031) & (K Units)
 Table 20. Global Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Region (2026-2031)
 Table 21. Global Long-acting Recombinant Human Erythropoietin Injections Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Long-acting Recombinant Human Erythropoietin Injections Revenue Market Share by Region (2020-2025)
 Table 23. Global Long-acting Recombinant Human Erythropoietin Injections Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Long-acting Recombinant Human Erythropoietin Injections Revenue Market Share by Region (2026-2031)
 Table 25. North America Long-acting Recombinant Human Erythropoietin Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Long-acting Recombinant Human Erythropoietin Injections Sales by Country (2020-2025) & (K Units)
 Table 27. North America Long-acting Recombinant Human Erythropoietin Injections Sales by Country (2026-2031) & (K Units)
 Table 28. North America Long-acting Recombinant Human Erythropoietin Injections Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Long-acting Recombinant Human Erythropoietin Injections Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Long-acting Recombinant Human Erythropoietin Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Long-acting Recombinant Human Erythropoietin Injections Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Long-acting Recombinant Human Erythropoietin Injections Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Long-acting Recombinant Human Erythropoietin Injections Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Long-acting Recombinant Human Erythropoietin Injections Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Long-acting Recombinant Human Erythropoietin Injections Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Long-acting Recombinant Human Erythropoietin Injections Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Long-acting Recombinant Human Erythropoietin Injections Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Long-acting Recombinant Human Erythropoietin Injections Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Long-acting Recombinant Human Erythropoietin Injections Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Long-acting Recombinant Human Erythropoietin Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Long-acting Recombinant Human Erythropoietin Injections Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Long-acting Recombinant Human Erythropoietin Injections Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Long-acting Recombinant Human Erythropoietin Injections Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Long-acting Recombinant Human Erythropoietin Injections Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Long-acting Recombinant Human Erythropoietin Injections Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Long-acting Recombinant Human Erythropoietin Injections Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Long-acting Recombinant Human Erythropoietin Injections Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Long-acting Recombinant Human Erythropoietin Injections Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Long-acting Recombinant Human Erythropoietin Injections Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Long-acting Recombinant Human Erythropoietin Injections Sales (K Units) by Type (2020-2025)
 Table 51. Global Long-acting Recombinant Human Erythropoietin Injections Sales (K Units) by Type (2026-2031)
 Table 52. Global Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Type (2020-2025)
 Table 53. Global Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Type (2026-2031)
 Table 54. Global Long-acting Recombinant Human Erythropoietin Injections Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Long-acting Recombinant Human Erythropoietin Injections Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Long-acting Recombinant Human Erythropoietin Injections Revenue Market Share by Type (2020-2025)
 Table 57. Global Long-acting Recombinant Human Erythropoietin Injections Revenue Market Share by Type (2026-2031)
 Table 58. Global Long-acting Recombinant Human Erythropoietin Injections Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Long-acting Recombinant Human Erythropoietin Injections Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Long-acting Recombinant Human Erythropoietin Injections Sales (K Units) by Application (2020-2025)
 Table 61. Global Long-acting Recombinant Human Erythropoietin Injections Sales (K Units) by Application (2026-2031)
 Table 62. Global Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Application (2020-2025)
 Table 63. Global Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Application (2026-2031)
 Table 64. Global Long-acting Recombinant Human Erythropoietin Injections Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Long-acting Recombinant Human Erythropoietin Injections Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Long-acting Recombinant Human Erythropoietin Injections Revenue Market Share by Application (2020-2025)
 Table 67. Global Long-acting Recombinant Human Erythropoietin Injections Revenue Market Share by Application (2026-2031)
 Table 68. Global Long-acting Recombinant Human Erythropoietin Injections Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Long-acting Recombinant Human Erythropoietin Injections Price (US$/Unit) by Application (2026-2031)
 Table 70. Amgen Company Information
 Table 71. Amgen Description and Business Overview
 Table 72. Amgen Long-acting Recombinant Human Erythropoietin Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Amgen Long-acting Recombinant Human Erythropoietin Injections Product
 Table 74. Amgen Recent Developments/Updates
 Table 75. Johnson & Johnson Company Information
 Table 76. Johnson & Johnson Description and Business Overview
 Table 77. Johnson & Johnson Long-acting Recombinant Human Erythropoietin Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Johnson & Johnson Long-acting Recombinant Human Erythropoietin Injections Product
 Table 79. Johnson & Johnson Recent Developments/Updates
 Table 80. Kyowa Kirin Company Information
 Table 81. Kyowa Kirin Description and Business Overview
 Table 82. Kyowa Kirin Long-acting Recombinant Human Erythropoietin Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Kyowa Kirin Long-acting Recombinant Human Erythropoietin Injections Product
 Table 84. Kyowa Kirin Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Long-acting Recombinant Human Erythropoietin Injections Distributors List
 Table 88. Long-acting Recombinant Human Erythropoietin Injections Customers List
 Table 89. Long-acting Recombinant Human Erythropoietin Injections Market Trends
 Table 90. Long-acting Recombinant Human Erythropoietin Injections Market Drivers
 Table 91. Long-acting Recombinant Human Erythropoietin Injections Market Challenges
 Table 92. Long-acting Recombinant Human Erythropoietin Injections Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Long-acting Recombinant Human Erythropoietin Injections
 Figure 2. Global Long-acting Recombinant Human Erythropoietin Injections Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Long-acting Recombinant Human Erythropoietin Injections Market Share by Type: 2024 & 2031
 Figure 4. Epoetin-alfa Product Picture
 Figure 5. Epoetin-beta Product Picture
 Figure 6. Darbepoetin-alfa Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Long-acting Recombinant Human Erythropoietin Injections Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Long-acting Recombinant Human Erythropoietin Injections Market Share by Application: 2024 & 2031
 Figure 10. Anemia
 Figure 11. Kidney Disorders
 Figure 12. Others
 Figure 13. Global Long-acting Recombinant Human Erythropoietin Injections Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Long-acting Recombinant Human Erythropoietin Injections Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Long-acting Recombinant Human Erythropoietin Injections Sales (2020-2031) & (K Units)
 Figure 16. Global Long-acting Recombinant Human Erythropoietin Injections Average Price (US$/Unit) & (2020-2031)
 Figure 17. Long-acting Recombinant Human Erythropoietin Injections Report Years Considered
 Figure 18. Long-acting Recombinant Human Erythropoietin Injections Sales Share by Manufacturers in 2024
 Figure 19. Global Long-acting Recombinant Human Erythropoietin Injections Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Long-acting Recombinant Human Erythropoietin Injections Players: Market Share by Revenue in Long-acting Recombinant Human Erythropoietin Injections in 2024
 Figure 21. Long-acting Recombinant Human Erythropoietin Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Long-acting Recombinant Human Erythropoietin Injections Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Country (2020-2031)
 Figure 24. North America Long-acting Recombinant Human Erythropoietin Injections Revenue Market Share by Country (2020-2031)
 Figure 25. United States Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Country (2020-2031)
 Figure 28. Europe Long-acting Recombinant Human Erythropoietin Injections Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Long-acting Recombinant Human Erythropoietin Injections Revenue Market Share by Region (2020-2031)
 Figure 36. China Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Long-acting Recombinant Human Erythropoietin Injections Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Long-acting Recombinant Human Erythropoietin Injections Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Long-acting Recombinant Human Erythropoietin Injections Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Long-acting Recombinant Human Erythropoietin Injections Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Long-acting Recombinant Human Erythropoietin Injections by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Long-acting Recombinant Human Erythropoietin Injections by Type (2020-2031)
 Figure 55. Global Long-acting Recombinant Human Erythropoietin Injections Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Long-acting Recombinant Human Erythropoietin Injections by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Long-acting Recombinant Human Erythropoietin Injections by Application (2020-2031)
 Figure 58. Global Long-acting Recombinant Human Erythropoietin Injections Price (US$/Unit) by Application (2020-2031)
 Figure 59. Long-acting Recombinant Human Erythropoietin Injections Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Long acting Recombinant Human Erythropoietin Market Research Report 2024
Global Long acting Recombinant Human Erythropoietin Drugs Market Research Report 2024
Global Long acting EPO Drugs Market Research Report 2024
Global Erythropoietin EPO Treatment Market Research Report 2024
Global Long acting ESAs Market Research Report 2024
Erythropoietin EPO Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Erythropoietin Stimulating Agents Market Insights Forecast to 2030
Global Recombinant Human Erythropoietin Injection Market Research Report 2025
Global Short acting Recombinant Human Erythropoietin Injections Market Research Report 2024
Global Recombinant Erythropoietin Drugs Market Insights Forecast to 2030
Global Short acting Recombinant Human Erythropoietin Drugs Market Research Report 2024
Global Erythropoietin Drugs Market Research Report 2024
Global Short acting EPO Drugs Market Research Report 2024
Erythropoietin Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Short acting Recombinant Human Erythropoietin Market Research Report 2024
Global Medical Erythropoietin Injection Market Research Report 2024
Global Recombinant Human Erythropoietin for Injection Market Research Report 2024
Global Medical Human Erythropoietin Injection Market Research Report 2024
Global Darbepoetin Alfa Market Insights Forecast to 2030
Epogen and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions